Russell Frank Company’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$12.1M	Buy	193,043 +65,691	+52%	+$4.37M	0.02%	831
2015 Q4	$12M	Buy	127,352 +97,758	+330%	+$9.06M	0.02%	786
2015 Q3	$2.38M	Sell	29,594 -28,088	-49%	-$3.12M	﹤0.01%	1748
2015 Q2	$6.91M	Buy	57,682 +4,846	+9%	+$579K	0.01%	1224
2015 Q1	$5.52M	Buy	52,836 +7,894	+18%	+$800K	0.01%	1194
2014 Q4	$4.36M	Sell	44,942 -6,900	-13%	-$639K	0.01%	1371
2014 Q3	$4.05M	Sell	51,842 -43,273	-45%	-$2.79M	0.01%	1411
2014 Q2	$5.11M	Sell	95,115 -39,919	-30%	-$2.37M	0.01%	1309
2014 Q1	$9.07M	Buy	135,034 +83,515	+162%	+$6.47M	0.02%	941
2013 Q4	$4.37M	Sell	51,519 -10,043	-16%	-$599K	0.01%	1300
2013 Q3	$3.94M	Buy	61,562 +7,266	+13%	+$362K	0.01%	1479
2013 Q2	$1.68M	Buy	+54,296	New	+$1.44M	﹤0.01%	1854